Literature DB >> 22382575

Molecular docking studies of protein-nucleotide complexes using MOLSDOCK (mutually orthogonal Latin squares DOCK).

Shankaran Nehru Viji1, Nagarajan Balaji, Namasivayam Gautham.   

Abstract

Understanding the principles of protein receptor recognition, interaction, and association with molecular substrates and inhibitors is of principal importance in the drug discovery process. MOLSDOCK is a molecular docking method that we have recently developed. It uses mutually orthogonal Latin square sampling (together with a variant of the mean field technique) to identify the optimal docking conformation and pose of a small molecule ligand in the appropriate receptor site. Here we report the application of this method to simultaneously identify both the low energy conformation and the one with the best pose in the case of 62 protein-bound nucleotide ligands. The experimental structures of all these complexes are known. We have compared our results with those obtained from two other well-known molecular docking software, viz. AutoDock 4.2.3 and GOLD 5.1. The results show that the MOLSDOCK method was able to sample a wide range of binding modes for these ligands and also scores them well.

Mesh:

Substances:

Year:  2012        PMID: 22382575     DOI: 10.1007/s00894-012-1369-4

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  30 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 2.  Three-dimensional structure of p21H-ras and its implications.

Authors:  F Wittinghofer
Journal:  Semin Cancer Biol       Date:  1992-08       Impact factor: 15.707

3.  Conformational studies on enkephalins using the MOLS technique.

Authors:  K Vengadesan; N Gautham
Journal:  Biopolymers       Date:  2004-08-15       Impact factor: 2.505

4.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

5.  An extensive test of 14 scoring functions using the PDBbind refined set of 800 protein-ligand complexes.

Authors:  Renxiao Wang; Yipin Lu; Xueliang Fang; Shaomeng Wang
Journal:  J Chem Inf Comput Sci       Date:  2004 Nov-Dec

6.  Protein-ligand docking using mutually orthogonal Latin squares (MOLSDOCK).

Authors:  S Nehru Viji; P Arun Prasad; N Gautham
Journal:  J Chem Inf Model       Date:  2009-12       Impact factor: 4.956

Review 7.  Ligand-protein docking and rational drug design.

Authors:  T P Lybrand
Journal:  Curr Opin Struct Biol       Date:  1995-04       Impact factor: 6.809

8.  Development and validation of a genetic algorithm for flexible docking.

Authors:  G Jones; P Willett; R C Glen; A R Leach; R Taylor
Journal:  J Mol Biol       Date:  1997-04-04       Impact factor: 5.469

9.  The structure of CMP:2-keto-3-deoxy-manno-octonic acid synthetase and of its complexes with substrates and substrate analogs.

Authors:  S Jelakovic; G E Schulz
Journal:  J Mol Biol       Date:  2001-09-07       Impact factor: 5.469

10.  Crystal structure of bacteriophage T4 deoxynucleotide kinase with its substrates dGMP and ATP.

Authors:  A Teplyakov; P Sebastiao; G Obmolova; A Perrakis; G S Brush; M J Bessman; K S Wilson
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

View more
  2 in total

1.  Protein-small molecule docking with receptor flexibility in iMOLSDOCK.

Authors:  D Sam Paul; N Gautham
Journal:  J Comput Aided Mol Des       Date:  2018-08-20       Impact factor: 3.686

2.  MOLS 2.0: software package for peptide modeling and protein-ligand docking.

Authors:  D Sam Paul; N Gautham
Journal:  J Mol Model       Date:  2016-09-16       Impact factor: 1.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.